Erasmus University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (37)

2020

  1. Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial

    Catheterization and Cardiovascular Interventions, Vol. 96, Núm. 5, pp. E516-E526

2019

  1. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: Analysis from the EXCEL trial

    Coronary Artery Disease, Vol. 30, Núm. 2, pp. 143-149

2018

  1. State of transcatheter aortic valve implantation in Spain versus Europe and non-European countries

    Journal of Invasive Cardiology, Vol. 30, Núm. 8, pp. 301-309

  2. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

    The Lancet, Vol. 392, Núm. 10151, pp. 940-949

2017

  1. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents

    Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 60-74

  2. Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey

    International Journal of Cardiology, Vol. 228, pp. 640-647

  3. Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease

    EuroIntervention, Vol. 13, Núm. 8, pp. 944-952

2016

  1. The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

    JACC: Cardiovascular Interventions, Vol. 9, Núm. 12, pp. 1231-1242

2015

  1. Use of intracoronary physiology indices in acute coronary syndromes

    Interventional Cardiology, Vol. 7, Núm. 5, pp. 483-495

2011

  1. Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial

    EuroIntervention, Vol. 6, Núm. 7, pp. 805-812

  2. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery

    New England Journal of Medicine, Vol. 364, Núm. 11, pp. 1016-1026

  3. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the RESOLUTE all comers trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)

    Journal of the American College of Cardiology, Vol. 57, Núm. 22, pp. 2221-2232

  4. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial

    JACC: Cardiovascular Interventions, Vol. 4, Núm. 4, pp. 432-441

2010

  1. 5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions

    Journal of the American College of Cardiology, Vol. 55, Núm. 11, pp. 1093-1101

  2. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

    New England Journal of Medicine, Vol. 363, Núm. 2, pp. 136-146

  3. Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial

    Circulation, Vol. 121, Núm. 10, pp. 1176-1187

  4. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

    EuroIntervention, Vol. 5, Núm. 8, pp. 962-967

2009

  1. Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS i and ARTS II

    EuroIntervention, Vol. 4, Núm. 4, pp. 492-501

  2. Foreword

    EuroIntervention

  3. Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: Analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II)

    Heart, Vol. 95, Núm. 13, pp. 1061-1066